Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3975-3979, September 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Q.
Right arrow Articles by Spitz, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Q.
Right arrow Articles by Spitz, M. R.

Benzo(a)pyrene Diol Epoxide-induced Chromosomal Aberrations and Risk of Lung Cancer1

Qingyi Wei2, Jun Gu, Lie Cheng, Melissa L. Bondy, Hong Jiang, Waun Ki Hong and Margaret R. Spitz

Departments of Epidemiology [Q. W., J. G., L. C., M. L. B., H. J., M. R. S.] and Thoracic and Head and Neck Medical Oncology [W. K. H.]. The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Benzo(a)pyrene is considered a classic DNA-damaging carcinogen and is one of a multitude of polycyclic aromatic hydrocarbons commonly found in tobacco smoke and in the ambient environment. In this report, we describe the characteristics of chromosomal aberrations induced in vitro by activated benzo(a)pyrene diol epoxide (BPDE) in lymphocyte cultures of 172 normal individuals ages 19–95 years and present the analysis of a pilot case-control study of 33 lung cancer patients and 96 selected controls without history of cancer and frequency matched on age (50–85 years) to the cases. The BPDE-induced chromosomal aberrations were predominantly single chromatid breaks, with few isochromatid breaks or exchange figures. In the 172 normal subjects, the frequencies of both spontaneous and BPDE-induced chromatid breaks were not correlated with age, sex, ethnicity, or tobacco use. However, the frequency of BPDE-induced chromatid breaks was significantly correlated with the frequency of spontaneous chromatid breaks (r = 0.19, P < 0.05). In addition, Hispanics had significantly higher mean BPDE-induced chromatid breaks than did non-Hispanic whites (P < 0.01). From the casecontrol analyses, the frequency of BPDE-induced chromosomal aberrations was significantly higher in cases (mean, 0.67 breaks/cell) than in controls (mean, 0.41 breaks/cell; P < 0.0001). An adjusted odds ratio of 6.53 (95% confidence interval, 3.74–11.4) for lung cancer was associated with increased frequency of these chromosomal aberrations. The higher rate of BPDE-induced chromosomal aberrations may be due to inefficient DNA repair. These findings warrant additional molecular epidemiological studies. The BPDE mutagen sensitivity assay will facilitate epidemiological studies of genetic susceptibility to smoking-related cancers.

1 This research work was supported by an institutional start-up fund grant (to Q. W.) and by NIH Grants CA55769 (to M. R. S.) and U19CA68437 (to W. K. H.).

2 To whom requests for reprints should be addressed, at Department of Epidemiology, Box 189, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030. Phone: (713) 792-3020; Fax: (713) 792-0807; E-mail: qwei@request.mda.uth.tmc.edu.

Received 4/29/96. Accepted 7/ 1/96.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Leng, A. Bernauer, C. A. Stidley, M. A. Picchi, X. Sheng, M. A. Frasco, D. Van Den Berg, F. D. Gilliland, R. E. Crowell, and S. A. Belinsky
Association between Common Genetic Variation in Cockayne Syndrome A and B Genes and Nucleotide Excision Repair Capacity among Smokers
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2062 - 2069.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. Orlow, B. J. Park, U. Mujumdar, H. Patel, P. Siu-Lau, B. A. Clas, R. Downey, R. Flores, M. Bains, N. Rizk, et al.
DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors
J. Clin. Oncol., July 20, 2008; 26(21): 3560 - 3566.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Leng, C. A. Stidley, A. M. Bernauer, M. A. Picchi, X. Sheng, M. A. Frasco, D. Van Den Berg, F. D. Gilliland, R. E. Crowell, and S. A. Belinsky
Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers
Carcinogenesis, July 1, 2008; 29(7): 1380 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei
Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck
Cancer Res., June 1, 2008; 68(11): 4479 - 4485.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I.A. Lea, M.A. Jackson, X. Li, S. Bailey, S.D. Peddada, and J.K. Dunnick
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns
Carcinogenesis, September 1, 2007; 28(9): 1851 - 1858.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz
A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma
Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
E. Erdei, S.-J. Lee, Q. Wei, L.-E. Wang, Y.-S. Song, D. Bovbjerg, and M. Berwick
Reliability of mutagen sensitivity assay: an inter-laboratory comparison
Mutagenesis, July 1, 2006; 21(4): 261 - 264.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. El-Zein, M. B. Schabath, C. J. Etzel, M. S. Lopez, J. D. Franklin, and M. R. Spitz
Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk.
Cancer Res., June 15, 2006; 66(12): 6449 - 6456.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell
{gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al.
In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis
J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Ahsan and A. G. Rundle
Measures of genotype versus gene products: promise and pitfalls in cancer prevention
Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Spitz, Q. Wei, Q. Dong, C. I. Amos, and X. Wu
Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 689 - 698.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. P. Medina, S. A. Ahrendt, M. Pollan, P. Fernandez, D. Sidransky, and M. Sanchez-Cespedes
Screening of Homologous Recombination Gene Polymorphisms in Lung Cancer Patients Reveals an Association of the NBS1-185Gln Variant and p53 Gene Mutations
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Xiong, M. L. Bondy, D. Li, H. Shen, L.-E Wang, S. E. Singletary, M. R. Spitz, and Q. Wei
Sensitivity to Benzo(a)pyrene Diol-Epoxide Associated with Risk of Breast Cancer in Young Women and Modulation by Glutathione S-Transferase Polymorphisms: A Case-Control Study
Cancer Res., December 1, 2001; 61(23): 8465 - 8469.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Schwarz, P. Kisselev, I. Cascorbi, W.-H. Schunck, and I. Roots
Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants
Carcinogenesis, March 1, 2001; 22(3): 453 - 459.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sanchez-Cespedes, S. A. Ahrendt, S. Piantadosi, R. Rosell, M. Monzo, L. Wu, W. H. Westra, S. C. Yang, J. Jen, and D. Sidransky
Chromosomal Alterations in Lung Adenocarcinoma from Smokers and Nonsmokers
Cancer Res., February 1, 2001; 61(4): 1309 - 1313.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
D. Li, P. F. Firozi, L.-E Wang, C. H. Bosken, M. R. Spitz, W. K. Hong, and Q. Wei
Sensitivity to DNA Damage Induced by Benzo(a)pyrene Diol Epoxide and Risk of Lung Cancer: A Case-Control Analysis
Cancer Res., February 1, 2001; 61(4): 1445 - 1450.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz
Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study
J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
G. H. Yoo, J. Washington, M. Piechocki, J. Ensley, T. Shibuya, D. Oda, and W.-Z. Wei
Progression of Head and Neck Cancer in an In Vitro Model
Arch Otolaryngol Head Neck Surg, November 1, 2000; 126(11): 1313 - 1318.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Cheng, M. R. Spitz, W. K. Hong, and Q. Wei
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis
Carcinogenesis, August 1, 2000; 21(8): 1527 - 1530.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Berwick and P. Vineis
Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
J Natl Cancer Inst, June 7, 2000; 92(11): 874 - 897.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. P. Perera
Molecular Epidemiology: On the Path to Prevention?
J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. P. Perera and I.B. Weinstein
Molecular epidemiology: recent advances and future directions
Carcinogenesis, March 1, 2000; 21(3): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
E. M. Sturgis, G. L. Clayman, Y. Guan, Z. Guo, and Q. Wei
DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 185 - 190.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
J. Cloos, C. B.A. Reid, M. L.T. van der Sterre, H. Tobi, C. R. Leemans, G. B. Snow, and B. J.M. Braakhuis
A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects
Mutagenesis, January 1, 1999; 14(1): 87 - 93.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.